Celltrion
068270.KS
#770
Rank
HK$200.66 B
Marketcap
HK$968.82
Share price
1.34%
Change (1 day)
-5.27%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : HK$113.48 Billion

According to Celltrion 's latest financial reports the company's total assets are HK$113.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31HK$36.50 B-1.82%
2021-12-31HK$37.18 B3.8%
2020-12-31HK$35.82 B37.8%
2019-12-31HK$25.99 B5.78%
2018-12-31HK$24.57 B1.79%
2017-12-31HK$24.14 B30.13%
2016-12-31HK$18.55 B6.52%
2015-12-31HK$17.41 B5.89%
2014-12-31HK$16.44 B13.02%
2013-12-31HK$14.55 B12.46%
2012-12-31HK$12.93 B37.25%
2011-12-31HK$9.42 B18.17%
2010-12-31HK$7.97 B111.8%
2009-12-31HK$3.76 B21.28%
2008-12-31HK$3.10 B500.39%
2007-12-31HK$0.51 B